INCPF
Price:
$1.55
Market Cap:
$13.98B
InnoCare Pharma Limited is a biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative treatments, primarily targeting cancer and autoimmune disorders. A key product in their portfolio is Orelabrutinib, a Bruton's tyrosine kinase (BTK) inhibitor. This therapy targets various relapsed or refractory blood cancers, including chronic lymphocytic leukemia, mantle cell lymphoma, Waldenstrom's macroglobulinemia, marginal zone lymphoma, diffuse large B-cell lymphoma (MCD subtype), central nervous system lymphoma, and is also being explored in combination with MIL-62. Furthermore, Orelabrutinib is under investigation for a range of autoimmune conditions su...[Read more]
Industry
Biotechnology
IPO Date
2021-07-09
Stock Exchange
OTC
Ticker
INCPF
According to InnoCare Pharma Limited’s latest financial reports and current stock price. The company's current ROE is 10.12%. This represents a change of 339.45% compared to the average of 2.30% of the last 4 quarters.
The mean historical ROE of InnoCare Pharma Limited over the last ten years is 20.71%. The current 10.12% ROE has changed -51.13% with respect to the historical average. Over the past ten years (40 quarters), INCPF's ROE was at its highest in in the December 2019 quarter at 49.56%. The ROE was at its lowest in in the June 2022 quarter at -5.91%.
Average
20.71%
Median
-1.15%
Minimum
-12.61%
Maximum
87.16%
Discovering the peaks and valleys of InnoCare Pharma Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 913.34%
Maximum Annual ROE = 87.16%
Minimum Annual Increase = -223.57%
Minimum Annual ROE = -12.61%
| Year | ROE | Change |
|---|---|---|
| 2025 | 8.10% | -223.57% |
| 2024 | -6.55% | -25.81% |
| 2023 | -8.83% | -24.32% |
| 2022 | -11.67% | 913.34% |
| 2021 | -1.15% | -90.87% |
| 2020 | -12.61% | -117.72% |
| 2019 | 71.17% | 17.03% |
| 2018 | 60.81% | -30.23% |
The current ROE of InnoCare Pharma Limited (INCPF) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-2.43%
5-year avg
-4.02%
10-year avg
20.71%
InnoCare Pharma Limited’s ROE is greater than Shanghai Junshi Biosciences Co., Ltd. (-10.78%), greater than Genscript Biotech Corporation (-12.72%), less than ALK-Abelló A/S (20.45%), less than Laboratorios Farmaceuticos Rovi, S.A. (20.89%), less than Zealand Pharma A/S (42.59%), less than Camurus AB (publ) (16.39%), less than COSMOS Pharmaceutical Corporation (11.80%), less than Fielmann AG (21.72%), less than Clicks Group Limited (51.45%), less than Gedeon Richter PLC (16.73%),
| Company | ROE | Market cap |
|---|---|---|
| -10.78% | $4.84B | |
| -12.72% | $3.50B | |
| 20.45% | $8.18B | |
| 20.89% | $4.63B | |
| 42.59% | $3.16B | |
| 16.39% | $3.21B | |
| 11.80% | $2.94B | |
| 21.72% | $4.17B | |
| 51.45% | $3.34B | |
| 16.73% | $4.54B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like InnoCare Pharma Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like InnoCare Pharma Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is InnoCare Pharma Limited's ROE?
How is the ROE calculated for InnoCare Pharma Limited (INCPF)?
What is the highest ROE for InnoCare Pharma Limited (INCPF)?
What is the 3-year average ROE for InnoCare Pharma Limited (INCPF)?
What is the 5-year average ROE for InnoCare Pharma Limited (INCPF)?
How does the current ROE for InnoCare Pharma Limited (INCPF) compare to its historical average?